Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Streptokinase and streptodornase
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Streptokinase 100,000u/Streptodornase 25,000u pdr & diluent
1311070R0AAAAAA
|
Streptokinase/Streptodornase | Streptokinase and streptodornase | Skin | No data available |
|
Streptokinase 100,000unit/Streptodornase 25,000unit pdr
1311070R0AAACAC
|
Streptokinase/Streptodornase | Streptokinase and streptodornase | Skin | No data available |
|
Varidase Topical 125,000unit powder vials
1311070R0BBACAC
|
Varidase | Streptokinase and streptodornase | Skin | No data available |
|
Varidase Topical 125,000unit powder vials and diluent
1311070R0BBAAAA
|
Varidase | Streptokinase and streptodornase | Skin | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.